Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / TSSK4

TSSK4

Basics

Aliases:
This biomarker is also known as:
  • testis-specific serine kinase 4,
  • Serine/threonine-protein kinase 22E,
  • TSSK-4,
  • STK22E,
  • chromosome 14 open reading frame 20,
  • C14orf20,
  • TSK-4,
  • serine/threonine kinase 22E,
  • TSSK5,
  • Testis-specific kinase 4,
  • Testis-specific serine/threonine-protein kinase 4,

View in BioMuta

Description…

TSSK4 may be involved in a signaling pathway during male germ cell development or mature sperm function. It phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. TSSK4 is expressed only in the testis.

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: TSSK4

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to http://grants.nih.gov /grants/guide/ pa-files/ PAR-15-289.html.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.